摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

chloromethyl 1,1-dimethyl-2-propynyl ether | 55812-22-1

中文名称
——
中文别名
——
英文名称
chloromethyl 1,1-dimethyl-2-propynyl ether
英文别名
chloromethyl 2-methyl-3-butyn-2-yl ether;1,1-dimethyl-2-propynyloxymethyl chloride;Chlormethyl-1,1-dimethyl-2-propinylether;Chlormethyl-1,1-dimethyl-2-propynylether;3-(chloromethoxy)-3-methylbut-1-yne
chloromethyl 1,1-dimethyl-2-propynyl ether化学式
CAS
55812-22-1
化学式
C6H9ClO
mdl
MFCD19232250
分子量
132.59
InChiKey
HCKOFCYWVRQJQR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    59-64 °C(Press: 70 Torr)
  • 密度:
    1.026±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    8
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.666
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    chloromethyl 1,1-dimethyl-2-propynyl ether1-methyl-1H-imidazole-2-carbaldehyde oxime四氢呋喃N,N-二甲基甲酰胺 为溶剂, 以50%的产率得到1-<<(1',1'-dimethyl-2'-propyn-1'-yl)oxy>methyl>-2-<(hydroxyimino)methyl>-3-methylimidazolium chloride
    参考文献:
    名称:
    Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 3. Synthesis and evaluation of (alkenyloxy)-, (alkynyloxy)-, and (aralykyloxy)methyl quaternarized 2-[(hydroxyimino)methyl]-1-alkylimidazolium halides as reactivators and therapy for soman intoxication
    摘要:
    A series of structurally related monosubstituted 1-[(alkenyloxy)methyl]-, 1-[(alkynyloxy)methyl]-, and 1-[(aralkyloxy)methyl]-2-[(hydroxyimino)methyl]-3-methyli midazolium halides were prepared and evaluated. All new compounds were characterized with respect to (hydroxyimino)methyl acid dissociation constant, nucleophilicity, and octanol-buffer partition coefficient. The alkynyloxy-substituted compounds were also evaluated in vitro with respect to reversible inhibition of human erythrocyte (RBC) acetylcholinesterase (AChE) and kinetics of reactivation of human AChE inhibited by ethyl p-nitrophenyl methylphosphonate (EPMP). In vivo evaluation in mice revealed that coadministration of alkynyloxy-substituted imidazolium compounds with atropine sulfate provided significant protection against a 2 x LD50 challenge of GD. For the alkynyloxy-substituted imidazolium drugs there is a direct relationship between in vitro and in vivo activity: the most potent in vivo compounds against GD proved to be potent in vitro reactivators against EPMP-inhibited human AChE. These results differ from the observations made on the sterically hindered imidazolium compounds (see previous article) and suggest that several antidotal mechanisms of protective action may be applicable for the imidazolium aldoxime family of therapeutics. The ability of the alkynyloxy substituents to provide life-saving protection against GD intoxication was not transferable to the pyridinium or triazolium heteroaromatic ring systems.
    DOI:
    10.1021/jm00122a035
  • 作为产物:
    描述:
    3-甲氧基甲氧基-3-甲基-丁-1-炔三氯化硼 作用下, 以 正己烷正戊烷 为溶剂, 反应 1.0h, 以51%的产率得到chloromethyl 1,1-dimethyl-2-propynyl ether
    参考文献:
    名称:
    Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 3. Synthesis and evaluation of (alkenyloxy)-, (alkynyloxy)-, and (aralykyloxy)methyl quaternarized 2-[(hydroxyimino)methyl]-1-alkylimidazolium halides as reactivators and therapy for soman intoxication
    摘要:
    A series of structurally related monosubstituted 1-[(alkenyloxy)methyl]-, 1-[(alkynyloxy)methyl]-, and 1-[(aralkyloxy)methyl]-2-[(hydroxyimino)methyl]-3-methyli midazolium halides were prepared and evaluated. All new compounds were characterized with respect to (hydroxyimino)methyl acid dissociation constant, nucleophilicity, and octanol-buffer partition coefficient. The alkynyloxy-substituted compounds were also evaluated in vitro with respect to reversible inhibition of human erythrocyte (RBC) acetylcholinesterase (AChE) and kinetics of reactivation of human AChE inhibited by ethyl p-nitrophenyl methylphosphonate (EPMP). In vivo evaluation in mice revealed that coadministration of alkynyloxy-substituted imidazolium compounds with atropine sulfate provided significant protection against a 2 x LD50 challenge of GD. For the alkynyloxy-substituted imidazolium drugs there is a direct relationship between in vitro and in vivo activity: the most potent in vivo compounds against GD proved to be potent in vitro reactivators against EPMP-inhibited human AChE. These results differ from the observations made on the sterically hindered imidazolium compounds (see previous article) and suggest that several antidotal mechanisms of protective action may be applicable for the imidazolium aldoxime family of therapeutics. The ability of the alkynyloxy substituents to provide life-saving protection against GD intoxication was not transferable to the pyridinium or triazolium heteroaromatic ring systems.
    DOI:
    10.1021/jm00122a035
点击查看最新优质反应信息

文献信息

  • 1-Methoxy-1-methyl-3-{p-[(1,1-dimethyl-2-propynyloxy)-methoxy]phenyl}urea
    申请人:American Cyanamid Company
    公开号:US04046797A1
    公开(公告)日:1977-09-06
    This invention relates to novel (alkenyloxy), (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas and their use as herbicidal agents.
    这项发明涉及新颖的(烯烷氧基)、(炔烷氧基)和(基烷氧基)烷氧基苯基类化合物及其作为除草剂的用途。
  • Novel (alkenyloxy)-, (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas
    申请人:American Cyanamid Company
    公开号:US04153448A1
    公开(公告)日:1979-05-08
    This invention relates to novel (alkenyloxy), (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas and their use as herbicidal agents.
    本发明涉及新型(烯丙氧基)、(炔丙氧基)和(基烷氧基)烷氧基苯基及其用作除草剂的用途。
  • (Alkenyloxy)-, (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas and
    申请人:American Cyanamid Company
    公开号:US04046808A1
    公开(公告)日:1977-09-06
    This invention relates to novel (alkenyloxy), (alkynyloxy) and (cyanoalkoxy) alkoxyphenyl ureas and their use as herbicidal agents.
    本发明涉及新型的(烯烃氧基)、(炔烃氧基)和(基烷氧基)烷氧基苯基,以及它们作为除草剂的应用。
  • Isothiazole derivatives containing (an) iodoalkylnyl group(s), their preparation and their use as fungicide and/or bactericide
    申请人:NIHON NOHYAKU CO., LTD.
    公开号:EP0697409A1
    公开(公告)日:1996-02-21
    An isothiazole derivative represented by the formula (I), wherein R¹ represents a hydrogen atom, C₁-C₆ alkyl, C₂-C₇ alkenyl, C₃-C₇ alkynyl, C₃-C₇ cycloalkyl, C₁-C₆ cyanoalkyl, C₁-C₆ haloalkyl, C₂-C₇ alkoxyalkyl, C₃-C₇ alkoxycarbonylalkyl, C₂-C₇ haloalkenyl, C₂-C₇ alkylcarbonyl, C₂-C₇ alkoxycarbonyl, iodoalkynyl, or iodoalkynyloxyalkyl group, R² represents a C₁-C₆ alkyl, C₂-C₇ alkenyl, C₃-C₇ alkynyl, C₃-C₇ cycloalkyl, C₁-C₆ cyanoalkyl, C₁-C₆ haloalkyl, C₂-C₇ alkoxyalkyl, C₃-C₇ alkoxycarbonylalkyl, C₂-C₇ haloalkenyl, C₂-C₇ alkylcarbonyl, C₂-C₇ alkoxycarbonyl, iodoalkynyl, or iodoalkynyloxyalkyl group, provided that at least one of R¹ and R² represents an iodoalkynyl or iodoalkynyloxyalkyl group, Y represents O or S, and Z represents O, S, SO, SO₂ or NR³ in which R³ represents a hydrogen atom, C₁-C₆ alkyl, C₂-C₇ alkenyl, C₃-C₇ alkynyl or benzyl group, or R³ and R², taken together, represent a C₃-C₅ alkylene group which may contain O or N, an agricultural, industrial and medical fungicides and/or bactericides containing said compound as an active ingredient.
    由式(I)代表的异噻唑生物、 其中 R¹ 代表氢原子、C₁-C₆烷基、C₂-C₇ 烯基、C₃-C₇ 炔基、C₃-C₇ 环烷基、C₁-C₆基烷基、C₁-C₆卤代烷基、C₂-C₇ 烷氧基烷基、C₃-C₇ 烷氧基羰基烷基、C₂-C₇ 卤代烯基、C₂-C₇ 烷基羰基、C₂-C₇ 烷氧基羰基、炔基或炔氧基烷基,R² 代表 C₁-C₆ 烷基、C₂-C₇ 烯基、C₃-C₇ 炔基、C₃-C₇ 环烷基、C₁-C₆基烷基、C₁-C₆卤代烷基、C₂-C₇ 烷氧基烷基、C₃-C₇烷氧羰基烷基、C₂-C₇卤代烯基、C₂-C₇烷基羰基、C₂-C₇烷氧基羰基、炔基或炔氧基烷基,条件是 R¹ 和 R² 中至少有一个代表炔基或炔氧基烷基,Y 代表 O 或 S、Z代表O、S、SO、SO₂或NR³,其中R³代表氢原子、C₁-C₆烷基、C₂-C₇烯基、C₃-C₇炔基或苄基,或R³和R²共同代表可含有O或N的C₃-C₅亚烷基、 含有上述化合物作为活性成分的农用、工业用和医用杀菌剂和/或杀菌剂。
  • Cleavage of methoxymethyl ethers with boron trichloride. A convenient, versatile preparation of chloromethyl ether derivatives
    作者:Dane A. Goff、Ralph N. Harris、Jeffrey C. Bottaro、Clifford D. Bedford
    DOI:10.1021/jo00374a040
    日期:1986.11
查看更多